Secretome Therapeutics

Private

Plano, Texas-based neonatal cardiac progenitor-cell (nCPC) therapy company (formerly NeoProgen). Lead asset STM-01 targets Duchenne muscular dystrophy-associated cardiomyopathy. Founded 2018.

Founders Vinny Jindal

CEO Vinny Jindal

Company

Founded

2018

Headquarters

Plano, USA

Financials

Total Funding

$30M

Sectors

Healthtech Biotech

secretometx.com

Funding History

1 round

Series A May 27, 2026

$30M

RA Capital Management (Lead)

Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.